Terbinafine Compared to Griseofulvin in Children With Tinea Capitis

Inclusion Criteria: * Patients with clinical diagnosis of tinea capitis confirmed by positive KOH determined by the central mycology laboratory. * Male or female patients who are at least 4 years old and no more than 12 years old. Exclusion Criteria: * Patients having a medical condition that alters the absorption and/or metabolism of terbinafine (e.g. liver, renal disease etc.) * Patients receiving medication that may interfere with the evaluation of the drug's effect * Patients who have kerions requiring immediate treatment or treatment with systemic corticosteroids and/or systemic antibiotics * Patients with a history of liver disease or current/active liver disease or with elevation of livery enzymes outside of the normal range corresponding to their age * Patients who have received recent systemic or topical treatment for tinea capitis within the specified time periods (e.g. systemic antifungals within 2 months of screening visit, topical treatments \[e.g. antifungals, corticosteroid preparations, zinc pyrithione or selenium sulfide or tar containing products\] within 1 week of screening). * Patients with a history of systemic lupus erythematosus